Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Expression of Kir4.1 and Kir5.1 inwardly rectifying potassium channels in oligodendrocytes, the myelinating cells of the CNS.
Autoimmune disease: SIRT1 inhibition suppresses multiple sclerosis.
Physiological Dynamics in Demyelinating Diseases: Unraveling Complex Relationships through Computer Modeling.
Steroids for chronic inflammatory demyelinating polyradiculoneuropathy: evidence base and clinical practice.
Exploration of changes in disability after menopause in a longitudinal multiple sclerosis cohort.
Epidemiology and genetic aspects of multiple sclerosis in India.
Novel composite MRI scale correlates highly with disability in multiple sclerosis patients.
S1P1 deletion in oligodendroglial lineage cells: Effect on differentiation and myelination.
Pharmacogenetics of multiple sclerosis: personalized therapy with immunomodulatory drugs.
Drug repurposing: a systematic approach to evaluate candidate oral neuroprotective interventions for secondary progressive multiple sclerosis.
Mitochondrial dysfunction contributes to neurodegeneration in multiple sclerosis.
Systematic network lesioning reveals the core white matter scaffold of the human brain.
Human mesenchymal stem cells target adhesion molecules and receptors involved in T cell extravasation.
Functional course of Progressive Multifocal Leukoencephalopathy.
Cardiac Sympathetic Hyperactivity in a Patient with Guillain-Barré Syndrome: An Analysis Using Cardiac [(123)I] Metaiodobenzylguanidine (MIBG) Scintigraphy.
Myeloid-derived suppressor cells expressing a self-antigen ameliorate experimental autoimmune encephalomyelitis.
Socio-economic factors and immigrant population studies of multiple sclerosis.
Vitamin D Modulates the Expression of IL-27 and IL-33 in the Central Nervous System in Experimental Autoimmune Encephalomyelitis (EAE).
The type I interferons: Basic concepts and clinical relevance in immune-mediated inflammatory diseases.
Homeostasis of Microglia in the Adult Brain: Review of Novel Microglia Depletion Systems.
Prognostic indicators of secondary progression in a paediatric-onset multiple sclerosis cohort in Kuwait.
Interferon-β Induces Hepatocyte Growth Factor in Monocytes of Multiple Sclerosis Patients.
NFATc1 deficiency in T cells protects mice from experimental autoimmune encephalomyelitis.
Identifying clues to molecular etiology of multiple sclerosis in South Indian patients.
SPG5 and multiple sclerosis: clinical and genetic overlap?
Pages
« first
‹ previous
…
658
659
660
661
662
663
664
665
666
…
next ›
last »